Evidence map›Paper›PMID 32453818›Full record

ArticleThe Journal of infectious diseases2020

MicroRNA Signature of Epithelial-Mesenchymal Transition in Group B Streptococcal Infection of the Placental Chorioamniotic Membranes.

Samantha Weed, Blair Armistead, Michelle Coleman, H Denny Liggit, Brian Johnson, Jesse Tsai, Richard P Beyer, Theodor K Bammler, Nicole M Kretzer, Ed Parker and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Samantha WeedDepartment of Obstetrics and Gynecology, University of Washington, Seattle Washington, USA.
Blair ArmisteadDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Michelle ColemanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
H Denny LiggitDepartment of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Brian JohnsonDepartment of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Jesse TsaiDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.
Richard P BeyerDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.
Theodor K BammlerDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington, USA.
Nicole M KretzerDepartment of Obstetrics and Gynecology, University of Washington, Seattle Washington, USA.
Ed ParkerDepartment of Ophthalmology, University of Washington, Seattle, Washington, USA.
Jeroen P VanderhoevenDepartment of Obstetrics and Gynecology, University of Washington, Seattle Washington, USA.
Craig J BierleCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Lakshmi RajagopalDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Kristina M Adams WaldorfDepartment of Obstetrics and Gynecology, University of Washington, Seattle Washington, USA.
University of Washington · USInfectious Disease Research Institute · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
WaNPRC Macaca nemestrina SPF Breeding ColonyU42OD011123 · OD · UNIVERSITY OF WASHINGTON · PI CHARLOTTE HOTCHKISS · 2012 to 2026
$34.4M
Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 1985 to 2026
$23.5M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI Sandra E Juul · 2020 to 2026
$9.9M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2014 to 2019
$7.9M
Role of the hyaluronidase in GBS VirulenceR01AI133976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2017 to 2021
$4.5M
Immune Control of Group B Streptococcal PlacentalR01AI145890 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2019 to 2023
$4.4M
NEI NIH HHS P30 EY001730NIAID NIH HHS R01 AI133976NIAID NIH HHS R01 AI145890NICHD NIH HHS P50 HD103524NICHD NIH HHS U54 HD083091NIH HHS P51 OD010425NIH HHS U42 OD011123
6 · The paper itself

Abstract

backgroundInfection-induced preterm birth is a major cause of neonatal mortality and morbidity and leads to preterm premature rupture of placental chorioamniotic membranes. The loss of amniotic epithelial cells and tensile strength preceding membrane rupture is poorly understood. We hypothesized that intrauterine bacterial infection induces changes in microRNA (miRNA) expression, leading to amniotic epithelial cell loss and membrane weakening.

methodsTen pregnant pigtail macaques received choriodecidual inoculation of either group B Streptococcus (GBS) or saline (n = 5/group). Placental chorioamniotic membranes were studied using RNA microarray and immunohistochemistry. Chorioamniotic membranes from women with preterm premature rupture of membranes (pPROM) and normal term pregnancies were studied using transmission electron microscopy.

resultsIn our model, an experimental GBS infection was associated with changes in the miRNA profile in the chorioamniotic membranes consistent with epithelial to mesenchymal transition (EMT) with loss of epithelial (E-cadherin) and gain of mesenchymal (vimentin) markers. Similarly, loss of desmosomes (intercellular junctions) was seen in placental tissues from women with pPROM.

conclusionsWe describe EMT as a novel mechanism for infection-associated chorioamniotic membrane weakening, which may be a common pathway for many etiologies of pPROM. Therapy based on anti-miRNA targeting of EMT may prevent pPROM due to perinatal infection.

Indexed as

AmnionAnimalsChorioamnionitisDisease Models, AnimalEpithelial-Mesenchymal TransitionFemaleHumansImmunohistochemistryMacaca nemestrinaMicroRNAsPregnancyPremature BirthPremature Rupture of Fetal MembranesStreptococcal InfectionsStreptococcus agalactiaeMicroRNAsanimal modelepithelial-mesenchymal transitionintrauterine infection preterm laborMacaca nemestrinamicroRNAmiR-200miR-203miR-205pPROMpreterm birth

Identifiers

PMID32453818
PMCPMC7751568
OpenAlexW3030682665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.